Apolipoprotein E (ApoE) polymorphism is related to differences in potential fertility in women: A case of antagonistic pleiotropy?

Proceedings of the Royal Society B: Biological Sciences

Volumn 282, Issue 1803, 2015, Pages

  Jasienska, Grazyna ^a   Ellison, Peter T ^b   Galbarczyk, Andrzej ^a   Jasienski, Michal ^c   Kalemba Drozdz, Malgorzata ^d   Kapiszewska, Maria ^d   Nenko, Ilona ^a   Thune, Inger ^e,f   Ziomkiewicz, Anna ^g  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b HARVARD UNIVERSITY   (United States)

^c Wyzsza Szkola Biznesu National Louis University   (Poland)

^d ANDRZEJ FRYCZ MODRZEWSKI KRAKOW UNIVERSITY   (Poland)

^e UNIVERSITY OF TROMSØ   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g Polish Academy of Sciences   (Poland)

Author keywords

Antagonistic pleiotropy; ApoE; Apolipoprotein polymorphism; Fertility; Progesterone

Indexed keywords

ALLELE; ANTAGONISM; FERTILIZATION (REPRODUCTION); GENE EXPRESSION; GENOTYPE; HORMONE; PLEIOTROPY; POLYMORPHISM; POPULATION STRUCTURE; PROTEIN; RISK FACTOR;

EID: 84922566888     PISSN: 09628452     EISSN: 14712954     Source Type: Journal    
DOI: 10.1098/rspb.2014.2395     Document Type: Article

References (75)

1. Williams GC, Nesse RM. 1991 The dawn of Darwinian medicine. Q. Rev. Biol. 66, 1–22. (doi:10.1086/417048)
2. Jasienska G. 2013 The fragile wisdom: an evolutionary view on women’s biology and health. Cambridge, MA: Harvard University Press.
3. Stearns SC. 2005 Issues in evolutionary medicine. Am. J. Hum. Biol. 17, 131–140. (doi:10.1002/ajhb.20105)
4. Jasienski M, Jasienska G. 2014 Nature–nurture interaction is ubiquitous, essential, but elusive. Curr. Anthropol. 55, 541–542.
5. Carter AJR, Nguyen AQ. 2011 Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles. BMC Med. Genet. 12, 160–173. (doi:10.1186/1471-2350-12-160)
6. Curtsinger JW, Service PM, Prout T. 1994 Antagonistic pleiotropy, reversal of dominance, and genetic-polymorphism. Am. Nat. 144, 210–228. (doi:10.1086/285671)
7. Zhang JZ, Wagner GP. 2013 On the definition and measurement of pleiotropy. Trends Genet. 29, 383–384. (doi:10.1016/j.tig.2013.05.002)
8. Delaney JR, Murakami CJ, Olsen B, Kennedy BK, Kaeberlein M. 2011 Quantitative evidence for early life fitness defects from 32 longevity-associated alleles in yeast. Cell Cycle 10, 156–165. (doi:10.4161/cc.10.1.14457)
9. Corbo RM, Ulizzi L, Piombo L, Scacchi R. 2008 Study on a possible effect of four longevity candidate genes (ACE, PON1, PPAR-gamma, and APOE) on human fertility. Biogerontology 9, 317–323. (doi:10.1007/s10522-008-9143-9)
10. Finch CE. 2010 Evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition. Proc. Natl Acad. Sci. USA 107, 1718–1724. (doi:10.1073/pnas.0909606106)
11. Zannis VI et al. 1982 Proposed nomenclature of APOE-isoproteins, APOE-genotypes, and phenotypes. J. Lipid Res. 23, 911–914.
12. Fullerton SM et al. 2000 Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am. J. Hum. Genet. 67, 881–900. (doi:10.1086/303070)
13. Takeda M, Martinez R, Kudo T, Tanaka T, Okochi M, Tagami S, Morihara T, Hashimoto R, Cacabelos R. 2010 Apolipoprotein E and central nervous system disorders: reviews of clinical findings. Psychiatry Clin. Neurosci. 64, 592–607. (doi:10.1111/j.1440-1819.2010.02148.x)
14. Farrer LA et al. 1997 Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease—a meta-analysis. JAMA 278, 1349–1356. (doi:10.1001/jama.278.16.1349)
15. Niu WQ, Qi Y, Qian YS, Gao PJ, Zhu DL. 2009 The relationship between apolipoprotein E epsilon 2/epsilon 3/epsilon 4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls. Hypertens. Res. 32, 1060–1066. (doi:10.1038/hr.2009.164)
16. Song YQ, Stampfer MJ, Liu SM. 2004 Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med. 141, 137–147. (doi:10.7326/0003-4819-141-2-200407200-00013)
17. Corbo RM, Scacchi R. 1999 Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? Ann. Hum. Genet. 63, 301–310. (doi:10.1046/j.1469-1809.1999.6340301.x)
18. Marchant NL, King SL, Tabet N, Rusted JM. 2010 Positive effects of cholinergic stimulation favor young APOE epsilon 4 carriers. Neuropsychopharmacology 35, 1090–1096. (doi:10.1038/npp.2009.214)
19. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE. 2009 Distinct patterns of brain activity in young carriers of the APOE-epsilon 4 allele. Proc. Natl Acad. Sci. USA 106, 7209–7214. (doi:10.1073/pnas.0811879106)
20. Oria RB, Patrick PD, Zhang H, Lorntz B, Costa CMD, Brito GAC, Barrett LJ, Lima AAM, Guerrant RL. 2005 APOE4 protects the cognitive development in children with heavy diarrhea burdens in northeast Brazil. Pediatr. Res. 57, 310–316. (doi:10.1203/01.pdr.00000148719.82468.ca)
21. Wozniak MA, Itzhaki RF, Faragher EB, James MW, Ryder SD, Irving WL. 2002 Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology 36, 456–463. (doi:10.1053/jhep.2002.34745)
22. Toniutto P et al. 2010 Genetic polymorphism at the apolipoprotein E locus affects the outcome of chronic hepatitis B. J. Med. Virol. 82, 224–231. (doi:10.1002/jmv.21642)
23. Kuhlmann I, Minihane AM, Huebbe P, Nebel A, Rimbach G. 2010 Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. Lipids Health Dis. 9, 8–22. (doi:10.1186/1476-511x-9-8)
24. Corbo RM, Ulizzi L, Scacchi R, Martinez-Labarga C, De Stefano GF. 2004 Apolipoprotein E polymorphism and fertility: a study in pre-industrial populations. Mol. Hum. Reprod. 10, 617–620. (doi:10.1093/molehr/gah082)
25. Ihle A, Bunce D, Kliegel M. 2012 APOE epsilon 4 and cognitive function in early life: a meta-analysis. Neuropsychology 26, 267–277. (doi:10.1037/a0026769)
26. Rougeron V, Woods CM, Tiedje KE, Bodeau-Livinec F, Migot-Nabias F, Deloron P, Luty AJF, Fowkes FJI, Day KP. 2013 Epistatic interactions between apolipoprotein E and hemoglobin S genes in regulation of malaria parasitemia. PLoS ONE 8, e76924. (doi:10.1371/journal.pone.0076924)
27. Jasienska G, Ziomkiewicz A, Thune I, Lipson SF, Ellison PT. 2006 Habitual physical activity and estradiol levels in women of reproductive age. Eur. J. Cancer Prev. 15, 439–445. (doi:10.1097/00008469-200610000-00009)
28. Pantelidis P, Lambert-Hammill M, Wierzbicki AS. 2003 Simple sequence-specific-primer-PCR methodto identify the three main apolipoprotein E haplotypes. Clin. Chem. 49, 1945–1948. (doi:10.1373/clinchem.2003.021683)
29. Hixson JE, Vernier DT. 1990 Restriction isotyping of human Apolipoprotein-E by gene amplification and cleavage with HhaI J. Lipid Res. 31, 545–548.
30. Jasienska G, Ziomkiewicz A, Ellison PT, Lipson SF, Thune I. 2004 Large breasts and narrow waists indicate high reproductive potential in women. Proc. R. Soc. Lond. B 271, 1213–1217. (doi:10.1098/rspb.2004.2712)
31. Lipson SF, Ellison PT. 1996 Comparison of salivary steroid profiles in naturally occurring conception and non-conception cycles. Hum. Reprod. 11, 2090–2096. (doi:10.1093/oxfordjournals.humrep.a019055)
32. Tabachnick BG, Fidell LS. 2013 Using multivariate statistics, 6th edn. Boston, MA: Pearson.
33. Wilkinson L, Blank G, Gruber C. 1996 Desktop data analysis with SYSTAT. Upper Saddle River, NJ: Prentice Hall.
34. Jasienska G, Ellison PT. 1998 Physical work causes suppression of ovarian function in women. Proc. R. Soc. Lond. B 265, 1847–1851. (doi:10.1098/rspb.1998.0511)
35. Jasienska G, Thune I, Ellison PT. 2006 Fatness at birth predicts adult susceptibility to ovarian suppression: an empirical test of the predictive adaptive response hypothesis. Proc. Natl Acad. Sci. USA 103, 12759–12762. (doi:10.1073/pnas.0605488103)
36. Ellison PT. 2003 Energetics and reproductive effort. Am. J. Hum. Biol. 15, 342–351. (doi:10.1002/ajhb.10152).
37. Nunez-de la Mora A, Chatterton RT, Choudhury OA, Napolitano DA, Bentley GR. 2007 Childhood conditions influence adult progesterone levels. PLoS Med. 4, e167. (doi:10.1371/journal.pmed.0040167)
38. Colleran H, Jasienska G, Nenko I, Galbarczyk A, Mace R. 2014 Community-level education accelerates the cultural evolution of fertility decline. Proc. R. Soc. B 281, 20132732. (doi:10.1098/rspb.2013.2732)
39. Ziomkiewicz A, Ellison PT, Lipson SF, Thune I, Jasienska G. 2008 Body fat, energy balance and estradiol levels: a study based on hormonal profiles from complete menstrual cycles. Hum. Reprod. 23, 2555–2563. (doi:10.1093/humrep/den213)
40. Jasienska G, Jasienski M. 2008 Interpopulation, interindividual, intercycle, and intracycle natural variation in progesterone levels: a quantitative assessment and implications for population studies. Am. J. Hum. Biol. 20, 35–42. (doi:10.1002/ajhb.20686)
41. McGuigan K. 2006 Studying phenotypic evolution using multivariate quantitative genetics. Mol. Ecol. 15, 883–896. (doi:10.1111/j.1365-294X.2006.02809.x)
42. Bednarska-Makaruk M, Broda G, Kurjata P, Rodo M, Roszczynko M, Rywik S, Wehr H. 2001 Apolipoprotein E genotype, lipid levels and coronary heart disease in a Polish population group. Eur. J. Epidemiol. 17, 789–792. (doi:10.1023/A:1015657709060)
43. Kowalska A, Wiechmann I, Walter H. 1998 Genetic variability of apolipoprotein E in a Polish population. Hum. Biol. 70, 1093–1099.
44. Ma F, Wang JH. 2013 Apolipoprotein epsilon 4-allele as a significant risk factor for conversion from mild cognitive impairment to Alzheimer’s disease: a meta-analysis of prospective studies. J. Mol. Neurosci. 50, 257–263. (doi:10.1007/s12031-012-9934-y)
45. Corbo RM, Scacchi R, Cresta M. 2004 Differential reproductive efficiency associated with common apolipoprotein E alleles in postreproductive-aged subjects. Fertil. Steril. 81, 104–107. (doi:10.1016/j.fertnstert.2003.05.029)
46. Norwitz ER, Schust DJ, Fisher SJ. 2001 Mechanisms of disease—implantation and the survival of early pregnancy. N. Engl. J. Med. 345, 1400–1408. (doi:10.1056/NEJMra000763)
47. Santoro N et al. 2000 Luteal progesterone relates to histological endometrial maturation in fertile women. J. Clin. Endocrinol. Metab. 85, 4207–4211. (doi:10.1210/jcem.85.11.6974)
48. Lu YC, Bentley GR, Gann PH, Hodges KR, Chatterton RT. 1999 Salivary estradiol and progesterone levels in conception and nonconception cycles in women: evaluation of a new assay for salivary estradiol. Fertil. Steril. 71, 863–868. (doi:10.1016/S0015-0282(99)00093-X)
49. Ioannidis G, Sacks G, Reddy N, Seyani L, Margara R, Lavery S, Trew G. 2005 Day 14 maternal serum progesterone levels predict pregnancy outcome in IVF/ICSI treatment cycles: a prospective study. Hum. Reprod. 20, 741–746. (doi:10.1093/humrep/deh644)
50. Habara T, Nakatsuka M, Konishi H, Asagiri K, Noguchi S, Kudo T. 2002 Elevated blood flow resistance in uterine arteries of women with unexplained recurrent pregnancy loss. Hum. Reprod. 17, 190–194. (doi:10.1093/humrep/17.1.190)
51. Bjuresten K, Landgren BM, Hovatta O, Stavreus-Evers A. 2011 Luteal phase progesterone increases live birth rate after frozen embryo transfer. Fertil. Steril. 95, 534–537. (doi:10.1016/j.fertnstert.2010.05.019)
52. Morris D, Diskin M. 2008 Effect of progesterone on embryo survival. Animal 2, 1112–1119. (doi:10.1017/s1751731108002474)
53. Sagare-Patil V, Vernekar M, Galvankar M, Modi D. 2013 Progesterone utilizes the PI3K-AKT pathway in human spermatozoa to regulate motility and hyperactivation but not acrosome reaction. Mol. Cell. Endocrinol. 374, 82–91. (doi:10.1016/j.mce.2013.04.005)
54. Hughes GC, Clark EA, Wong AH. 2013 The intracellular progesterone receptor regulates CD4(þ) T cells and T cell-dependent antibody responses. J. Leukoc. Biol. 93, 369–375. (doi:10.1189/jlb.1012491)
55. Arck P, Solano ME, Walecki M, Meinhardt A. 2014 The immune privilege of testis and gravid uterus: same difference? Mol. Cell. Endocrinol. 382, 509–520. (doi:10.1016/j.mce.2013.09.022)
56. Hu J, Zhang ZH, Shen WJ, Azhar S. 2010 Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr. Metab. 7, 47. (doi:10.1186/1743-7075-7-47)
57. Azhar S, Leers-Sucheta S, Reaven E. 2003 Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and ‘selective’ pathway connection. Front. Biosci. 8, S998–S1029. (doi:10.2741/1165)
58. Azhar S, Reaven E. 2002 Scavenger receptor class BI and selective cholesteryl ester uptake: partners in the regulation steroidogenesis. Mol. Cell. Endocrinol. 195, 1–26. (doi:10.1016/s0303-7207(02)00222-8)
59. Finch CE, Sapolsky RM. 1999 The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol. Aging 20, 407–428. (doi:10.1016/s0197-4580(99)00053-6)
60. Finch CE, Stanford CB. 2004 Meat-adaptive genes and the evolution of slower aging in humans. Q. Rev. Biol. 79, 3–50. (doi:10.1086/381662)
61. Hales CN, Barker DJP. 1992 Type-2 (non-insulin-dependent) diabetes mellitus—the thrifty phenotype hypothesis. Diabetologia 35, 595–601. (doi:10.1007/BF00400248)
62. Mondadori CRA et al. 2007 Better memory and neural efficiency in young apolipoprotein E epsilon 4 carriers. Cereb. Cortex 17, 1934–1947. (doi:10.1093/cercor/bhl103)
63. Filbey FM, Slack KJ, Sunderland TP, Cohen RM. 2006 Functional magnetic resonance imaging and magnetoencephalography differences associated with APOE epsilon 4 in young healthy adults. Neuroreport 17, 1585–1590. (doi:10.1097/01.wnr.0000234745.27571.d1)
64. Burt TD et al. 2008 Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon 4/epsilon 4 genotype accelerates HIV disease progression. Proc. Natl Acad. Sci. USA 105, 8718–8723. (doi:10.1073/pnas.0803526105)
65. Shima K, Kuhlenbaumer G, Rupp J. 2010 Chlamydia pneumoniae infection and Alzheimer’s disease: a connection to remember? Med. Microbiol. Immunol. (Berl). 199, 283–289. (doi:10.1007/s00430-010-0162-1)
66. Fujioka H, Phelix CF, Friedland RP, Zhu XW, Perry EA, Castellani RJ, Perry G. 2013 Alipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimer’s disease. J. Health Care Poor Underserved 24, 70–78. (doi:10.1353/hpu.2014.0009)
67. Meng FT, Wang YL, Liu J, Zhao J, Liu RY, Zhou JN. 2012 ApoE genotypes are associated with age at natural menopause in Chinese females. Age 34, 1023–1032. (doi:10.1007/s11357-011-9287-4)
68. Zetterberg H et al. 2002 Influence of the apolipoprotein E epsilon 4 allele on human embryonic development. Neurosci. Lett. 324, 189–192. (doi:10.1016/s0304-3940(02)00198-2)
69. Collazo MS, Porrata-Doria T, Flores I, Acevedo SF. 2012 Apolipoprotein E polymorphisms and spontaneous pregnancy loss in patients with endometriosis. Mol. Hum. Reprod. 18, 372–377. (doi:10.1093/molehr/gas004)
70. Henderson BE, Feigelson HS. 2000 Hormonal carcinogenesis. Carcinogenesis 21, 427–433. (doi:10.1093/carcin/21.3.427)
71. Wiebe JP. 2006 Progesterone metabolites in breast cancer. Endocrine-Related Cancer 13, 717–738. (doi:10.1677/erc.1.01010).
72. Jasienska G, Thune I, Ellison PT. 2000 Energetic factors, ovarian steroids and the risk of breast cancer. Eur. J. Cancer Prev. 9, 231–239. (doi:10.1097/00008469-200008000-00003)
73. Surekha D, Vishnupriya S, Sailaja K, Rao DN, Raghtinadharao D. 2008 Influence of apolipoprotein E gene polymorphism on the risk for breast cancer. Int. J. Hum. Genet. 8, 277–282.
74. Chang NW, Chen DR, Wu CT, Aouizerat BE, Chen FN, Hung SJ, Wang SH, Wei MF, Chang CS. 2005 Influences of apolipoprotein E polymorphism on the risk for breast cancer and HER2/neu status in Taiwan. Breast Cancer Res. Treat. 90, 257–261. (doi:10.1007/s10549-004-4656-7)
75. Saadat M. 2012 Apolipoprotein E (APOE) polymorphisms and susceptibility to breast cancer: a meta-analysis. Cancer Res. Treat. 44, 121–126. (doi:10.4143/crt.2012.44.2.121)